Publication of Equity Research

Summary by AI BETAClose X

Renalytix confirmed that two brokers, SP Angel and Oberon Capital, have initiated equity coverage and published research notes on Research Tree and their research portals, increasing analyst visibility; the company also confirmed FDA authorization and Medicare reimbursement for its KidneyIntelX.dkd test and that the test is commercially offered across the United States, reinforcing commercial access and potential revenue opportunity; these developments — two new coverage initiations and confirmed US market/reimbursement status — may increase investor attention, liquidity and perceived commercial upside.

Disclaimer*

UK 100

Latest directors dealings